NCT01295697View on ClinicalTrials.gov

Study of EZN-2208 Pediatric Patients With Solid Tumors

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

January 31, 2013

Conditions
Solid Tumors
Interventions
DRUG

EZN-2208

Experimental

Trial Locations (4)

19104

Rochelle Bagatell, MD (Principal Investigator), Philadelphia

77030

Jodi Muscal, MD, Houston

80045

Lia Gore, MD, Aurora

02115

Suzanne Shusterman, MD, Boston

Sponsors
All Listed Sponsors
lead

Enzon Pharmaceuticals, Inc.

INDUSTRY